首页 | 本学科首页   官方微博 | 高级检索  
检索        

长链非编码RNA DLX6-AS1在结肠癌组织与细胞中的表达及其临床意义
引用本文:魏琳琳,张 娜,郭 红,张尧天,王天禄,孙超南.长链非编码RNA DLX6-AS1在结肠癌组织与细胞中的表达及其临床意义[J].现代肿瘤医学,2019,0(13):2349-2353.
作者姓名:魏琳琳  张 娜  郭 红  张尧天  王天禄  孙超南
作者单位:中国医科大学肿瘤医院(辽宁省肿瘤医院)放疗科,辽宁 沈阳 110042
基金项目:辽宁省自然科学基金(编号:201602452)
摘    要:目的:检测长链非编码RNA DLX6-AS1(distal-less homeobox 6 antisense 1)在结肠癌组织和细胞中的表达,探讨DLX6-AS1与结肠癌临床病理特征及预后间的关系。方法:利用RT-PCR检测结肠癌组织、细胞及配对癌旁组织、黏膜上皮细胞中DLX6-AS1的表达;利用单因素方差分析DLX6-AS1与结肠癌患者临床病理特征之间的关系;利用生存曲线分析DLX6-AS1与结肠癌患者术后5年生存率的关系;利用Cox风险比例模型分析DLX6-AS1与结肠癌患者预后的关系。结果:DLX6-AS1在结肠癌组织、细胞中表达水平高于癌旁组织和结肠上皮细胞;DLX6-AS1的表达与结肠癌TNM分期相关(P<0.05);DLX6-AS1高表达的结肠癌患者术后5年生存率低于低表达的患者,DLX6-AS1表达是结肠癌患者独立的预后因素。结论:DLX6-AS1在结肠癌中表达升高,并与结肠癌患者生存及预后密切相关。

关 键 词:长链非编码RNADLX6-AS1  结肠癌  预后  生存

Expression and clinical significance of long non-coding RNA DLX6-AS1 in colon cancer tissues and cells
Wei Linlin,Zhang Na,Guo Hong,Zhang Yaotian,Wang Tianlu,Sun Chaonan.Expression and clinical significance of long non-coding RNA DLX6-AS1 in colon cancer tissues and cells[J].Journal of Modern Oncology,2019,0(13):2349-2353.
Authors:Wei Linlin  Zhang Na  Guo Hong  Zhang Yaotian  Wang Tianlu  Sun Chaonan
Institution:Department of Radiotherapy,Liaoning Cancer Hospital & Institute,China Medical University,Liaoning Shenyang 110042,China.
Abstract:Objective:To investigate the expression level of long non-coding RNA(lncRNA) DLX6-AS1 in colon cancer,and evaluate its prognostic value in colon cancer.Methods:Colon cancer cells and colon mucosal cells were tested in this study.Cancer tissue as well as adjacent normal tissue from patients diagnosed with colon cancer were also harvested in this study.Expression of DLX6-AS1 was measured by real-time PCR.ANOVA analysis was performed to evaluate the association between DLX6-AS1 and clinical manifestation of colon cancer patients.K-M survival analysis was utilized to determine correlation of DLX6-AS1 expression with 5-year survival.Cox's proportional hazards regression models were applied to analyze the relationships between DLX6-AS1 and prognosis of colon cancer patients.Results:DLX6-AS1 was upregulated in colon cancer tissues and cells compared with normal tissues and cells.Expression of DLX6-AS1 was closely associated with TNM stage of colon cancer(P<0.05).Expression of DLX6-AS1 was negatively correlated with 5-year survival rate.DLX6-AS1 is an independent prognostic risk factor of colon cancer.Conclusion:LncRNA DLX6-AS1 is upregulated in colon cancer and is negatively associated with survival outcome of colon cancer.
Keywords:lncRNA DLX6-AS1  colon cancer  prognosis  survival
本文献已被 维普 等数据库收录!
点击此处可从《现代肿瘤医学》浏览原始摘要信息
点击此处可从《现代肿瘤医学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号